department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Doxorubicin Hydrochloride · pharmadog

pharmadog
drugs
Doxorubicin Hydrochloride

drug

patient view →

Doxorubicin Teva

Marketedupdated 2mo ago

by Teva Pharmaceuticals USA Inc

Approved

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 64 investigational indications.

indications

investigational

Breast Cancer

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Doxorubicin Hydrochloride

generic

doxorubicin

MOA

DNA topoisomerase II alpha inhibitor

indication

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 13m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 8

tagApproval60 co-mentions · 30 sources
drugDOXIL (LIPOSOMAL)59 co-mentions · 30 sources
drugDoxil59 co-mentions · 30 sources
drugdoxorubicin31 co-mentions · 31 sources
drugFarmiblastina31 co-mentions · 31 sources
drugdoxorubicin hydrochloride30 co-mentions · 30 sources
drugprednisolone1 co-mentions · 1 sources
companyCity of Hope1 co-mentions · 1 sources

Trials studying Doxorubicin Teva

phase3A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)recruitingn=960
phase2Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemiarecruitingn=30
phase2Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Caactive not recruitingn=46
phase3A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancerrecruitingn=480
phase2Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphomarecruitingn=257
phase2Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcomarecruitingn=406
phase3Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)recruitingn=800
phase3Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Canceractive not recruitingn=927

more trials →